The use of teicoplanin in a patient with acute intermittent porphyria
Yükleniyor...
Dosyalar
Tarih
2005
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
E I F T Srl
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Acute intermittent porphyria is an autosomal
dominant disorder caused by a defect in porphobilinogen deaminase activity. The latent form of the
disease may exist indefinitely. Certain antimicrobial
agents, infections, and excessive dieting (starvation)
can precipitate attacks. Also, the safety of many of
the drugs used in the treatments of acute intermittent porphyria patients is unknown 1. In this letter
we reported the safety of using teicoplanin in a
patient with acute intermittent porphyria.
Açıklama
Anahtar Kelimeler
Teicoplanin, Acute Intermittent Porphyria
Kaynak
Journal Of Chemotherapy
WoS Q Değeri
Q3
Scopus Q Değeri
Q3
Cilt
17
Sayı
5
